All In MedTech

Device Trial Radar · NCT07782619

Agreement of Two OCT Biometers: A Pilot Study

Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Aug 17, 2026

Primary completion

Jan 2027

Study completion Jan 2027

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Aug 24, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 21 years

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the measurements obtained with two different biometers, UNITY Dx and Anterion. In eye care, a biometer is a device that uses laser technology to take highly precise measurements of the eye's internal structures. It is most frequently used to help determine the exact power of the intraocular lens (IOL) needed before cataract removal.

Conditions

  • Anterior Segment of Eye
  • Axial Length
  • Biometrics Measurement

Interventions

  • UNITY DXDevice

    Investigational non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

  • ANTERIONDevice

    Commercially available non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Regression-Based Axial Length (R-AL)Time frame: Day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Eye Institute of Utah

    Salt Lake City, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.